The Department of Justice's Civil Rights Division announced civil rights investigations into 15 additional medical schools on Thursday, examining whether these federally-funded institutions engaged in unlawful racial discrimination through race-conscious admissions practices. The investigations represent an expansion of the administration's recent enforcement actions against medical schools accused of considering race as a factor in admissions decisions. The department indicated it will scrutinize admissions policies at schools receiving millions in federal funding, seeking to determine compliance with civil rights laws prohibiting discrimination.

Medical school applicants, current students, and faculty at these 15 institutions face potential policy changes resulting from these investigations. Students enrolled through diversity-focused admissions programs may see their institutional standing questioned, while future applicants could face altered admissions criteria if investigations lead to settlements or policy modifications. Medical schools themselves confront legal and financial pressure to modify admissions processes, potentially reducing consideration of socioeconomic background and underrepresented minority status in selection decisions.

This action extends the Trump administration's broader campaign against race-conscious policies across federal education enforcement, aligning with the Supreme Court's 2023 decision striking down affirmative action in college admissions. The DOJ investigations follow similar probes into undergraduate institutions and represent a systematic effort to eliminate diversity considerations from educational access. This pattern echoes the administration's approach to civil rights enforcement seen across multiple agencies, prioritizing colorblind policies over systemic equity remedies.

The legal mechanism uses the Civil Rights Division's enforcement authority under Title VI of the Civil Rights Act of 1964, which prohibits discrimination by institutions receiving federal funds. Medical schools may challenge findings through administrative proceedings or federal court litigation. Potential reversal would require either a change in DOJ enforcement priorities under a subsequent administration or Congressional action to protect institutional autonomy in admissions decisions.